People who inject drugs remain hard-to-reach population across all HIV continuum stages in Central, Eastern and South Eastern Europe - data from Euro-guidelines in Central and Eastern Europe Network
- PMID: 30786803
- DOI: 10.1080/23744235.2019.1565415
People who inject drugs remain hard-to-reach population across all HIV continuum stages in Central, Eastern and South Eastern Europe - data from Euro-guidelines in Central and Eastern Europe Network
Abstract
Background/objectives: Inadequate HIV care for hard-to-reach populations may result in failing the UNAIDS 90-90-90 goal. Therefore, we aimed to review the HIV continuum of care and hard-to-reach populations for each step of the continuum in Central, Eastern and South Eastern Europe.
Methods: Euro-guidelines in Central and Eastern Europe (ECEE) Network Group were created in February 2016. The aim of the network was to review the standards of HIV care in the countries of the region. Information about each stage of HIV continuum of care and hard-to-reach populations for each stage was collected through on-line surveys. Respondents were ECEE members chosen based on their expertise and involvement in national HIV care. Data sources (year 2016) used by respondents included HIV Clinics electronic databases, Institutes of Public Health, Centres for AIDS Prevention, and HIV Programme Reviews.
Results: The percentage of people living with HIV (PLHIV) linked to HIV care after HIV diagnosis was ranged between 80% and 96% in Central Europe, 51% and 92% in Eastern Europe and 80% and 100% in South-Eastern Europe. The percentage of PLHIV who are on ART was ranged from 80% to 93% in Central Europe, 18% to 92% in Eastern Europe and 80% to 100% in South-Eastern Europe. The percentage of people virologically suppressed while on ART was reported as 70-95%, 12-95% and 62-97% in Central, Eastern, and South Eastern Europe, respectively. All three regions reported people who inject drugs (PWID) as hard-to-reach population across all HIV continuum stages. Migrants were the second most reported hard-to-reach population. The proportion of late presenters among newly diagnosed ranged between 20% and 55%, 40% and 55% and 48% and 60% in Central, Eastern and South Eastern Europe, respectively. Four countries reported ARVs' delivery delays resulting in treatment interruptions in 2016: two (25%) in South-Eastern, one (20%) in Central and 1 (16.7%) in Eastern Europe.
Conclusion: Irrespective of the diversity in national HIV epidemics, countries from all three regions reported PWIDs as hard-to-reach population across all HIV continuum stages. Some countries are close to the UNAIDS 2020 goals, others need to strive for progress. However, differences in data sources and variations in definitions limit the utility of continuum of care as a comparative tool.
Keywords: ART; Central Europe; EACS; ECEE; Eastern Europe; HIV; South Eastern Europe; care continuum; hard-to-reach.
Similar articles
-
The risk of HIV transmission at each step of the HIV care continuum among people who inject drugs: a modeling study.BMC Public Health. 2017 Jul 25;17(1):614. doi: 10.1186/s12889-017-4528-9. BMC Public Health. 2017. PMID: 28738861 Free PMC article.
-
HIV health care providers are ready to introduce pre-exposure prophylaxis in Central and Eastern Europe and neighbouring countries: data from the Euroguidelines in Central and Eastern Europe (ECEE) Network Group.HIV Med. 2018 Oct;19(9):629-633. doi: 10.1111/hiv.12641. Epub 2018 Jul 10. HIV Med. 2018. PMID: 29989332
-
Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?Clin Infect Dis. 2020 Dec 31;71(11):2905-2916. doi: 10.1093/cid/ciaa696. Clin Infect Dis. 2020. PMID: 32960957 Free PMC article.
-
HIV/AIDS prevalence in the Southern Caucasus.Georgian Med News. 2010 Dec;(189):26-36. Georgian Med News. 2010. PMID: 21252406 Review.
-
HIV treatment, antiretroviral adherence and AIDS mortality in people who inject drugs: a scoping review.Eur J Public Health. 2023 Jun 1;33(3):381-388. doi: 10.1093/eurpub/ckad008. Eur J Public Health. 2023. PMID: 36723859 Free PMC article.
Cited by
-
Could 30 years of political controversy on needle exchange programmes in Sweden contribute to scaling-up harm reduction services in the world?Nordisk Alkohol Nark. 2021 Feb;38(1):66-88. doi: 10.1177/1455072520965013. Epub 2020 Dec 17. Nordisk Alkohol Nark. 2021. PMID: 35309093 Free PMC article.
-
A View of Human Immunodeficiency Virus Infections in the North-West Region of Romania.Medicina (Kaunas). 2019 Nov 29;55(12):765. doi: 10.3390/medicina55120765. Medicina (Kaunas). 2019. PMID: 31795444 Free PMC article.
-
Determinants of HIV-1 Late Presentation in Patients Followed in Europe.Pathogens. 2021 Jul 2;10(7):835. doi: 10.3390/pathogens10070835. Pathogens. 2021. PMID: 34357985 Free PMC article.
-
Schistosomiasis screening in non-endemic countries from a cost perspective: Knowledge gaps and research priorities. The case of African long-term residents in a Metropolitan Area, Spain.PLoS Negl Trop Dis. 2023 Apr 4;17(4):e0011221. doi: 10.1371/journal.pntd.0011221. eCollection 2023 Apr. PLoS Negl Trop Dis. 2023. PMID: 37014919 Free PMC article.
-
Participation of the nursing workforce to address COVID-19 among people who use alcohol, tobacco, and drugs.Int J Drug Policy. 2020 Sep;83:102831. doi: 10.1016/j.drugpo.2020.102831. Epub 2020 Jul 3. Int J Drug Policy. 2020. PMID: 32654929 Free PMC article. No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical